IRIS - Res&Arch Institutional Research Information System - Research & Archive

MARTELLI, Maria Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.364
EU - Europa 4.931
AS - Asia 4.913
SA - Sud America 858
Continente sconosciuto - Info sul continente non disponibili 615
AF - Africa 141
OC - Oceania 11
Totale 18.833
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.121
SG - Singapore 2.244
IT - Italia 1.262
IE - Irlanda 712
CN - Cina 651
BR - Brasile 646
HK - Hong Kong 609
RU - Federazione Russa 604
VN - Vietnam 531
SE - Svezia 490
UA - Ucraina 483
DE - Germania 336
FI - Finlandia 274
FR - Francia 252
KR - Corea 201
GB - Regno Unito 167
CA - Canada 124
IN - India 104
BD - Bangladesh 103
TR - Turchia 89
AR - Argentina 81
IQ - Iraq 57
AT - Austria 51
NL - Olanda 50
MX - Messico 45
ZA - Sudafrica 43
CO - Colombia 42
ID - Indonesia 37
PL - Polonia 33
UZ - Uzbekistan 33
BE - Belgio 32
LU - Lussemburgo 31
PH - Filippine 30
CZ - Repubblica Ceca 29
JP - Giappone 29
CH - Svizzera 27
ES - Italia 26
PK - Pakistan 26
EC - Ecuador 24
SA - Arabia Saudita 24
MA - Marocco 22
VE - Venezuela 17
JM - Giamaica 16
LB - Libano 16
CL - Cile 14
LT - Lituania 14
RO - Romania 14
MY - Malesia 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
CR - Costa Rica 12
PY - Paraguay 12
ET - Etiopia 11
IL - Israele 10
JO - Giordania 10
KE - Kenya 10
TH - Thailandia 10
BO - Bolivia 9
GR - Grecia 9
NP - Nepal 9
TN - Tunisia 9
AU - Australia 8
EG - Egitto 8
EU - Europa 8
KZ - Kazakistan 8
NI - Nicaragua 8
OM - Oman 8
EE - Estonia 7
PA - Panama 7
PE - Perù 7
SC - Seychelles 7
GT - Guatemala 6
KG - Kirghizistan 6
AL - Albania 5
DZ - Algeria 5
PT - Portogallo 5
QA - Qatar 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
RS - Serbia 4
SV - El Salvador 4
AO - Angola 3
BH - Bahrain 3
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
GD - Grenada 3
KW - Kuwait 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SN - Senegal 3
UG - Uganda 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
HR - Croazia 2
HU - Ungheria 2
Totale 18.194
Salva come PNG Salva come JPEG
Città #
Singapore 1.590
Chandler 768
Dublin 712
San Jose 688
Hong Kong 604
Ashburn 586
Perugia 502
San Mateo 369
Santa Clara 289
Boardman 288
Council Bluffs 260
Jacksonville 227
Dong Ket 216
Moscow 212
Seoul 200
Lauterbourg 173
Beijing 164
Altamura 161
Medford 157
Princeton 153
Los Angeles 148
New York 135
Wilmington 125
Lawrence 118
Munich 117
Andover 113
Ann Arbor 109
Ho Chi Minh City 109
Helsinki 92
Dallas 87
Piscataway 78
The Dalles 69
Des Moines 67
São Paulo 59
Turku 59
Hanoi 58
Milan 44
Orem 44
Rome 43
Izmir 42
Phoenix 42
Saint Petersburg 41
Frankfurt am Main 36
San Francisco 34
Brooklyn 32
Brussels 32
Chicago 32
Falls Church 32
Montreal 32
Belo Horizonte 30
Dudelange 30
Johannesburg 28
Norwalk 28
Redmond 28
Denver 27
Toronto 27
Charlotte 26
Houston 26
Pisa 26
Rio de Janeiro 26
Tokyo 26
Baghdad 25
London 25
Nuremberg 25
San Paolo di Civitate 25
Woodbridge 24
Amsterdam 23
Buffalo 23
Chennai 22
Shanghai 20
Tashkent 20
Vienna 20
Atlanta 19
Dhaka 19
Haiphong 19
Warsaw 19
Mexico City 18
Redwood City 18
Bologna 17
Boston 17
Florence 16
Stockholm 16
Jakarta 15
New Orleans 15
Poplar 15
Foligno 14
Manchester 14
Riverbank 14
Bogotá 13
Falkenstein 13
Manila 13
Auburn Hills 12
Brasília 12
Columbus 12
Hefei 12
Kingston 12
New Delhi 12
Ankara 11
Barnet 11
Bucharest 11
Totale 11.337
Salva come PNG Salva come JPEG
Nome #
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 218
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 216
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 186
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 185
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 176
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 168
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 166
Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells. 160
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. 151
Maesopsin 4-O-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN! and BCAS3 in acute myeloid leukemia 149
ARPIR: automatic RNA-Seq pipelines with interactive report 148
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 146
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 146
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 145
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 142
Mutant NPM1 Maintains the Leukemic State through HOX Expression 139
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 139
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita 138
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. 136
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features 135
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 134
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF. 132
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 131
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 129
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 129
Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to Sumo-1 in murine thymocytes 128
Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy? 125
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 124
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 123
EML4-ALK rearrangement in non-small-cell lung cancer and non-tumor lung tissues. 122
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 122
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 121
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 119
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 119
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 118
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues. 118
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 118
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia. 117
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 117
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 117
Pharmacological modulation of caspase-8 in thymus-related medical conditions. 116
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 115
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 115
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 115
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 114
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 113
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 113
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 113
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 112
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 112
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 112
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 111
BRAF mutations in hairy-cell leukemia. 111
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity 111
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 109
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 109
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 109
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 106
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 106
Current status and future perspectives in targeted therapy of NPM1-mutated AML 105
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 105
Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission? 105
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. 105
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 105
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia 105
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 105
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 104
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 104
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 104
Stem cell mobilization in normal donors. 103
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 103
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. 103
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 102
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 102
Cellular and Molecular Biology of Lymphoid Cell 101
Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients 101
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 101
Failure of gelsolin overexpression to regulate lymphocyte apoptosis. 100
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 100
CYTOPLASMIC MUTATED NUCLEOPHOSMIN DEFINES THE MOLECULAR STATUS OF A SIGNIFICANT FRACTION OF MYELOID SARCOMAS 100
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor 99
BRAF V600E mutation in hairy cell leukemia: From bench to bedside 99
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 98
Poor risk acute myelogenous leukemia patients undergoing the Fludarabine-Cytosine Arabinoside-Filgrastim regimen: multidrug resistance expression, granulocyte colony-stimulating factor priming activity and clinical response. 98
Flower cells of tropical descent: a challenging case of adult T-cell leukemia/lymphoma 98
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 98
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 98
Overlapping features of therapy-related and de novoNPM1-mutated AML 97
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. 97
MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. 97
Fibrin-associated large B-cell lymphoma: first case report within a cerebral artery aneurysm and literature review 97
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) 97
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by 67 Gallium scan in 50 patients. 96
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family. 95
Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML 94
Mutational landscape of AML with normal cytogenetics: biological and clinical implications 94
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy 93
ADDITION OF THIOTEPA IMPROVES RESULTS IN T-CELL DEPLETED BONE-MARROW TRANSPLANT FOR ADVANCED LEUKEMIA 92
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. 91
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 90
Totale 11.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.489
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.207 0 0 0 80 64 23 17 394 30 130 239 230
2022/20232.503 167 459 24 200 203 289 5 111 916 35 69 25
2023/20241.063 54 112 66 21 10 7 249 12 83 49 196 204
2024/20253.014 109 251 164 136 371 131 170 244 541 163 482 252
2025/20266.553 445 393 287 771 891 620 1.014 401 791 673 177 90
2026/20271.433 194 391 444 404 0 0 0 0 0 0 0 0
Totale 18.833